Management of chronic hepatitis in drug addicts: A systematic review

Adriano M. Pellicelli, G. Barbaro, G. Barbarini, F. Soccorsi

Research output: Contribution to journalArticle

Abstract

Injection drug users constitute the largest group of person at high risk for acquiring chronic hepatitis C, B and Delta. In particular viral, host and environmental factors all seem to favour rapid spread of these infections among drugs addicts. Host factors include behaviours that expose individuals to hepatitis virus such as the shared use of drug preparation, injection equipment and not protected sexual relationship with other drugs users. While in some clinical studies adherence to treatment regimens was often poor and to treat chronic hepatitis in injection drug users was stated as futile, in other controlled clinical studies adherence and sustained biological response to antiviral treatment was slightly lower or similar to that reported in other groups of patients. In this review we describe the epidemiology, diagnosis and treatment of chronic hepatitis C, B and Delta in intravenous drug users.

Original languageEnglish
Pages (from-to)41-49
Number of pages9
JournalClinica Terapeutica
Volume159
Issue number1
Publication statusPublished - Jan 2008

Keywords

  • Chronic viral hepatitis
  • Drugs addiction
  • Interferon alpha

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management of chronic hepatitis in drug addicts: A systematic review'. Together they form a unique fingerprint.

  • Cite this

    Pellicelli, A. M., Barbaro, G., Barbarini, G., & Soccorsi, F. (2008). Management of chronic hepatitis in drug addicts: A systematic review. Clinica Terapeutica, 159(1), 41-49.